The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study
ConclusionOur study reveals concomitant ribavirin as the only independent predictor of transient decrease in SF-36 mental HRQL during DAA therapy. In contrast to interferon-based therapy, DAAs do not affect BMI or Jamar HGS.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Clinical Trials | Haemophilia | Hemophilia | Hepatitis | Hepatitis C | Infectious Diseases | Men | Netherlands Health | Nutrition | Sports Medicine | Study